Pisano Wayne's Form 4 filing
Altimmune, Inc. (ALT) · filed Dec 22, 2022
- Accession no.
- 0001104659-22-129514
- Filed
- Dec 22, 2022
- Trade date
- Dec 22, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $300.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pisano WayneCIK 0001743611 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 | Common Stock, par value $0.0001 | MOption exerciseAcquired | +20,000 | $2.60 | +$52,000 | 28,498 | Direct | |
| Dec 22, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −20,000 | $15.01 | −$300,200 | 8,498 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 | Common Stock, par value $0.0001 | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.